BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22244787)

  • 1. Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects.
    Bu J; Feng Q; Ran J; Li Q; Mei G; Zhang Y
    Diabetes Res Clin Pract; 2012 May; 96(2):163-9. PubMed ID: 22244787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes.
    Lu HL; Wang HW; Wen Y; Zhang MX; Lin HH
    World J Gastroenterol; 2006 Mar; 12(11):1747-51. PubMed ID: 16586545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
    Zaidi SI; Shirwany TA
    J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipokine profiles in preeclampsia.
    Chandrasekaran S; Hunt H; Melhorn S; Gammill HS; Schur EA
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2812-2817. PubMed ID: 30572749
    [No Abstract]   [Full Text] [Related]  

  • 5. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results.
    Stepien M; Rosniak-Bak K; Paradowski M; Misztal M; Kujawski K; Banach M; Rysz J
    Med Sci Monit; 2011 Nov; 17(11):PR13-18. PubMed ID: 22037753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of weight reduction on insulin resistance, adhesive molecules and adipokines dysregulation among obese type 2 diabetic patients.
    Abd El-Kader SM; Al-Jiffri OH
    Afr Health Sci; 2018 Dec; 18(4):873-883. PubMed ID: 30766550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
    Osei K; Gaillard T; Schuster D
    Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population.
    Yuan T; Zhao WG; Sun Q; Fu Y; Dong YY; Dong YX; Yang GH; Wang H
    Chin Med J (Engl); 2010 Aug; 123(15):2018-22. PubMed ID: 20819535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
    Al-Harithy RN; Al-Ghamdi S
    Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
    Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
    Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin is Associated with Inflammation and Renal Function, but not with Insulin Resistance in Type 2 Diabetes.
    Rzepa Ł; Peller M; Eyileten C; Rosiak M; Kondracka A; Mirowska-Guzel D; Opolski G; Filipiak KJ; Postuła M; Kapłon-Cieslicka A
    Horm Metab Res; 2021 Jul; 53(7):478-484. PubMed ID: 34169498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals.
    Peti A; Juhasz A; Kenyeres P; Varga Z; Seres I; Kovacs GL; Paragh G; Bajnok L
    J Endocrinol Invest; 2011 Jan; 34(1):21-5. PubMed ID: 20460954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
    Abdullah K; Al-Habori M; Al-Eryani E
    Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans.
    Utzschneider KM; Carr DB; Tong J; Wallace TM; Hull RL; Zraika S; Xiao Q; Mistry JS; Retzlaff BM; Knopp RH; Kahn SE
    Diabetologia; 2005 Nov; 48(11):2330-3. PubMed ID: 16143861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.
    Bahia L; Aguiar LG; Villela N; Bottino D; Godoy-Matos AF; Geloneze B; Tambascia M; Bouskela E
    Clinics (Sao Paulo); 2006 Oct; 61(5):433-40. PubMed ID: 17072441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.
    Hivert MF; Sullivan LM; Fox CS; Nathan DM; D'Agostino RB; Wilson PW; Meigs JB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3165-72. PubMed ID: 18492747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
    Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D
    J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
    Silha JV; Krsek M; Skrha JV; Sucharda P; Nyomba BL; Murphy LJ
    Eur J Endocrinol; 2003 Oct; 149(4):331-5. PubMed ID: 14514348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.